Mithra Pharmaceuticals SA announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 12.142 million compared to EUR 2.507 million a year ago. Operating loss was EUR 36.534 million compared to EUR 32.840 million a year ago. Net loss was EUR 54.894 million compared to EUR 33.994 million a year ago.